Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 738

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9
Chunk 738
---
ophysics from the Indian Institute of Science, Bangalore, and completed postdoctoral
training at the University of Minnesota and the Scripps Research Institute, La Jolla, California.

Myron W. Shulgan KC has served as
a member of our board of directors since January 2025. Mr. Shulgan is a lawyer who has over 40 years of trial experience.
He was a partner at Strosberg Sasso Sutts LLP from 2015 to 2024. Early in his career he worked as a federally appointed drug prosecutor
for three years where he prosecuted individuals charged with drug related offences. During this period he developed his trial skills.
Since then he has developed a trial practice during which he has represented corporations and individuals involved in complex commercial
litigation, construction claims, banking disputes and other business related matters in trials and appeals in all levels of Courts in
Canada including the Supreme Court of Canada. Mr. Shulgan has acted for and counselled clients in the manner in which they could
navigate the maze of laws in highly regulated businesses to assist them in achieving their goals to ensure that they comply with their
government mandated obligations. Mr. Shulgan received a bachelor of arts degree in political science and a bachelor of law degree
from the University of Windsor.

On January 27, 2025, Bright Green Corp. (“BGXX”) entered
into a Restructuring Support Agreement (the “RSA”) with Lynn Stockwell, BGXX’s CEO, Chair of the Board and majority
shareholder and the Company’s Chief Executive Officer and Executive Chair of the Board, reflecting an agreement to implement a prepackaged
restructuring of BGXX through the commencement of voluntary Chapter 11 cases under the United States Bankruptcy Code and the submission
of a prepackaged Chapter 11 plan. As contemplated by the RSA, on February 22, 2025, BGXX filed a voluntary petition in the United States
Bankruptcy Court for the District of New Mexico for relief under Chapter 11 of the Bankruptcy Code, thereby commencing the Chapter 11
case.

Number and Terms of Office and Appointment
of Officers and Directors

Our board of directors consists of four members.

Approval of our entry into an initial business
combination agreement will require the affirmative vote of a majority of our board directors, which must include a majority of our independent
directors. Subject to any other special rights applicable to the shareholders, prior to our initial business combination